EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EBS Technologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10917
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. Its Eyetronic Therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. EBS’s Eyetronic Therapy stimulates the metabolism of the neurons in order to restore the function and to stop further cell degeneration. The company’s products are available in selected European markets. EBS is headquartered in Kleinmachnow, Germany.

EBS Technologies GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Norgine Ventures Management Invests up to USD3.5 Million in EBS Technologies 11
EBS Technologies Raises up to USD3.5 Million in Venture Financing 12
EBS Technologies Raises USD1.21 Million in Venture Financing 13
EBS Technologies GmbH – Key Competitors 14
EBS Technologies GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Key Facts 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Norgine Ventures Management Invests up to USD3.5 Million in EBS Technologies 11
EBS Technologies Raises up to USD3.5 Million in Venture Financing 12
EBS Technologies Raises USD1.21 Million in Venture Financing 13
EBS Technologies GmbH, Key Competitors 14

List of Figures
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ASV Holdings, Inc. (ASV):企業の財務・戦略的SWOT分析
    ASV Holdings, Inc. (ASV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Energias de Portugal SA:発電所・企業SWOT分析
    Energias de Portugal SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Yanmar Co Ltd:企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • IndiPharm Inc-製薬・医療分野:企業M&A・提携分析
    Summary IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protoc …
  • VentriPoint Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company provides ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. I …
  • Swedish Match AB:企業の戦略・SWOT・財務情報
    Swedish Match AB - Strategy, SWOT and Corporate Finance Report Summary Swedish Match AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Orchid Pharma Ltd (ORCHIDPHAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Hwange Colliery Co Ltd:企業の戦略・SWOT・財務分析
    Hwange Colliery Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hwange Colliery Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dyadic International Inc (DYAI)-製薬・医療分野:企業M&A・提携分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that discovers, develops, manufactures and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila (C1) expression system, to conduct research and produce industria …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Amscan Holdings, Inc.:企業の戦略・SWOT・財務情報
    Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Voith Hydro Holding GmbH & Co KG:企業の戦略的SWOT分析
    Voith Hydro Holding GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Entasis Therapeutics Inc (ETTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Entasis Therapeutics Inc (Entasis) is a drug development company that discovers and develops anti-infective therapies for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, ETX0282, ETX0914 and Zoliflodacin. Its ETX2514 is a potent inhibitor of class A, C, …
  • Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Cutispharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CutisPharma Inc (CutisPharma) is a pharmaceutical company that develops and distributes kits. The company offers products such as oral suspensions, suppositories, oral solutions, and topical, among others. Its oral solutions and oral suspensions include mouthwashes, anti-microbial, and PPIs; …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable) is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by which solar energy is converted to …
  • Fortis Healthcare Ltd (FORTIS):企業の財務・戦略的SWOT分析
    Fortis Healthcare Ltd (FORTIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Transgene SA (TNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆